Clinical Evaluation of the Analgesic Effect of Sustained Release Morphine Sulfate Microgranules in Patients with Terminal Cancer

被引：0
|
作者：
Guo-Zhu Xu
Zhi-Ji Cai
Yan-Ping Deng
Jun Hou
Guang-Ru Xie
Shu-Jun Liu
机构：
[1] Beijing Medical University,National Institute on Drug Dependence
[2] Hebei Cancer Institute,College of Oncology
[3] Tianjin Cancer Hospital,undefined
[4] Beijing Medical University,undefined
来源：
Clinical Drug Investigation | 1997年 / 14卷
关键词：
Adis International Limited; Pain Relief; Sustained Release; Numerical Rating Scale; Drug Invest;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A randomised controlled clinical trial evaluating the analgesic effect of capsules containing sustained release (SR) morphine sulfate microgranules (M-Eslon®) was conducted in 120 patients with terminal cancer and moderate or severe pain. SR morphine sulfate as a tablet formulation (MS-Contin®) was used as the control drug. Both drugs were administered orally at dosages of 20mg (lower dosage) or 30mg (higher dosage) every 12 hours for 7 days. The parameters for pain assessment were pain intensity, evaluated on a 1 to 10 numerical rating scale, and pain relief (PAR), evaluated on a 5-grade scale.
引用
收藏
页码：34 / 42
页数：8
相关论文
共 50 条
  • [31] AN EVALUATION OF THE EFFECT OF FOOD ON THE ORAL BIOAVAILABILITY OF SUSTAINED-RELEASE MORPHINE-SULFATE TABLETS (ORAMORPH SR) AFTER MULTIPLE DOSES
    BASS, J
    SHEPARD, KV
    LEE, JW
    HULSE, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (11): : 1003 - 1007
  • [32] Retrospective analysis of Kadian® (morphine sulfate sustained-release capsules) in patients with chronic, nonmalignant pain
    Chao, J
    PAIN MEDICINE, 2005, 6 (03) : 262 - 265
  • [33] MULTIPLE-DOSE PHARMACOKINETIC EVALUATION OF 2 FORMULATIONS OF SUSTAINED-RELEASE MORPHINE-SULFATE TABLETS
    SCHOBELOCK, MJ
    SHEPARD, KV
    MOSDELL, KW
    LEE, J
    HULSE, JD
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (10): : 1009 - 1021
  • [34] Comparative bioavailability of sustained-release morphine sulfate capsules versus pellets
    Broomhead, A
    West, R
    Kadirgamanathan, G
    Knox, K
    Krueger, D
    Malick, J
    CLINICAL DRUG INVESTIGATION, 1997, 14 (02) : 137 - 145
  • [35] PHARMACOKINETICS OF PARENTERAL AND ORAL SUSTAINED-RELEASE MORPHINE-SULFATE IN DOGS
    DOHOO, S
    TASKER, RAR
    DONALD, A
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1994, 17 (06) : 426 - 433
  • [36] Pharmacokinetics of oral morphine sulfate in dogs: A comparison of sustained release and conventional formulations
    Dohoo, SE
    Tasker, RAR
    CANADIAN JOURNAL OF VETERINARY RESEARCH-REVUE CANADIENNE DE RECHERCHE VETERINAIRE, 1997, 61 (04): : 251 - 255
  • [37] Comparative Bioavailability of Sustained-Release Morphine Sulfate Capsules versus Pellets
    Alan Broomhead
    Raelene West
    Gaithry Kadirgamanathan
    Kaye Knox
    Don Krueger
    Jeffrey Malick
    Clinical Drug Investigation, 1997, 14 : 137 - 145
  • [38] PLACEBO-BLINDED STUDY OF MORPHINE-SULFATE SUSTAINED-RELEASE TABLETS AND IMMEDIATE-RELEASE MORPHINE-SULFATE SOLUTION IN OUTPATIENTS WITH CHRONIC PAIN DUE TO ADVANCED CANCER
    FINN, JW
    WALSH, TD
    MACDONALD, N
    BRUERA, E
    KREBS, LU
    SHEPARD, KV
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) : 967 - 972
  • [39] In vivo evaluation of a new sustained-release formulation of morphine
    Araico, A.
    Saadeddin, A.
    Torres-Molina, F.
    Peris, J. E.
    PHARMAZIE, 2009, 64 (10): : 653 - 655
  • [40] BIOAVAILABILITY AND ANALGESIC EFFECT OF SUSTAINED-RELEASE CETOBEMIDONE CAPSULES IN CANCER-PATIENTS WITH CHRONIC PAIN OF MALIGNANT ORIGIN
    KJAER, M
    NIELSEN, H
    OLSEN, FE
    ANDERSEN, LS
    PHILIPSEN, J
    VELANDER, G
    ACTA ONCOLOGICA, 1992, 31 (05) : 577 - 583
12345